Lamassu Pets – LamassuBiotech

03/25/2026

Ohio State Launches Clinical Trial for Promising New Treatment for Acute Pancreatitis in Dogs

Study could transform care for a leading cause of hospitalizations in pets and people (COLUMBUS, OH) - Acute pancreatitis is a painful, life-threatening condition that affects an estimated 1.8 million...

READ THE ARTICLE

07/29/2025

LAMASSU PETS NAMES FORMER NOVARTIS, PIEDMONT ANIMAL HEALTH EXECUTIVE MICHAEL KELLY AS STRATEGIC ADVISOR

(DURHAM, NC) – Lamassu Pets, the veterinary division of Lamassu Biotech, has announced the appointment of veteran animal health industry executive Michael Kelly to its Advisory Board. Widely respected in the animal health pharmaceutical sector, Kelly brings more...

READ THE ARTICLE

06/06/2025

Crain’s Cleveland Business: Cleveland biotech company secures $2.7M in NIH funding

Lamassu Biotech, a company with its “second headquarters” in Cleveland, has received a $2.7 million grant from the National Institutes of Health (NIH). The funds will help support the development...

READ THE ARTICLE